Summary
Alzinova AB (Alzinova) focuses on the discovery and development of therapeutics for Alzheimer’s disease. The company develops AßCC peptide technology which offers long-term research and development capabilities towards several ends, including the discovery and development of novel therapeutics, research tools and services. Alzinova also develops oligomer-directed vaccine ALZ-101 and the diagnostics based on the monoclonal antibody ALZ-201. It offers peptide technology that develops therapeutics against the meta-stable soluble amyloid. The company provides development of highly specific oligomer-directed vaccine, as well as on the development of diagnostics based on a monoclonal antibody. It operates through its laboratory located in Goteborg. Alzinova is headquartered in Gothenburg, Sweden.
Alzinova AB (ALZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzinova AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alzinova AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alzinova AB, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Alzinova Acquires IP Rights To AßCC Platform Technology And ALZ-201 From MIVAC Development 10
Venture Financing 11
Alzinova Raises Funds Through Venture Financing 11
Partnerships 11
Alzinova Enters into Agreement with Clinical Research Services Turku 11
Equity Offering 12
Alzinova Raises USD2 Million in IPO of Units 12
Alzinova Raises USD0.5 Million in Private Placement of Shares 13
Alzinova AB - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List of Tables
Alzinova AB, Pharmaceuticals & Healthcare, Key Facts 1
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzinova AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzinova AB, Deals By Therapy Area, 2011 to YTD 2017 8
Alzinova AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alzinova Acquires IP Rights To AßCC Platform Technology And ALZ-201 From MIVAC Development 10
Alzinova Raises Funds Through Venture Financing 11
Alzinova Enters into Agreement with Clinical Research Services Turku 11
Alzinova Raises USD2 Million in IPO of Units 12
Alzinova Raises USD0.5 Million in Private Placement of Shares 13
Alzinova AB, Key Competitors 14
Alzinova AB, Key Employees 15
Alzinova AB, Other Locations 16
List of Figures
Alzinova AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alzinova AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8